Menu Back to Clinical-Trials-Workshop-II-Translating-the-New-Transparency-Requirements-into-Practice

Program Committee

  • Sabine  Atzor, RPh
    Sabine Atzor, RPh Head of EU Regulatory Policies F. Hoffmann-La Roche Ltd., Switzerland
  • Nick  Sykes, MS
    Nick Sykes, MS Senior Director, Worldwide Safety & Regulatory Pfizer Ltd., United Kingdom
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Director, Global Clinical Registry Novo Nordisk A/S, Denmark
  • Hanns-Georg  Leimer, PhD
    Hanns-Georg Leimer, PhD Head of Transparency, Disclosure, and Application Governance within Medical Boehringer Ingelheim Pharma GmbH&CO KG, Germany
  • Robert  Paarlberg, MS
    Robert Paarlberg, MS Principal Paarlberg & Associates LLC, United States
Load More